Insider Transactions in Q1 2023 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2023
|
Nadav Kidron President and CEO |
BUY
Open market or private purchase
|
Indirect |
26,000
+17.11%
|
$52,000
$2.04 P/Share
|
|
Mar 14
2023
|
Nadav Kidron President and CEO |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$200,000
$2.01 P/Share
|
|
Mar 14
2023
|
Miriam Kidron Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
100,000
-33.15%
|
$200,000
$2.01 P/Share
|
|
Mar 14
2023
|
Yadin Rozov Director |
BUY
Open market or private purchase
|
Direct |
50,000
+36.63%
|
$100,000
$2.05 P/Share
|
|
Mar 13
2023
|
Yadin Rozov Director |
BUY
Open market or private purchase
|
Direct |
20,000
+35.4%
|
$20,000
$1.96 P/Share
|
|
Jan 03
2023
|
Michael Rabinowitz Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,325
-4.82%
|
$159,900
$12.75 P/Share
|